European Heart Journal

Article	Citations
Development and uptake of the National Heart Foundation of Australia Smart Heart Guideline App	7310
ESC 2021 named lectures: science, research, and innovation	3413
Single- vs dual-chamber ICDs to prevent from inappropriate shocks: the debate is still alive	2915
Association between family history and severity of coronary artery disease in a nationwide sample of patients with a first time myocardial infarction	1717
Fibroblast growth factor 21 and adipose tissue distribution in young adult with abdominal obesity	1269
Efficacy and safety of direct oral anticoagulants with diabetes and nonvalvular atrial fibrillation: a systematic review and meta-analysis	1258
Ticagrelor monotherapy versus dual anti-platelet therapy in patients undergoing percutaneous coronary intervention: a subgroup analysis of safety in multiple comorbidities	1138
The impact of diabetes mellitus on carotid atherosclerosis and arterial stiffness; results from the Corinthia study	1130
Evaluation of different late left ventricular remodeling definitions for predicting long-term outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention	699
Local areas of earlier repolarization cause epicardial repolarization heterogeneity in patients with apparently idiopathic ventricular fibrillation	683
His bundle pacing: safety, performance, and clinical outcomes in a single centre experience	666
Outcome and clinical profile of patients with newly detected atrial fibrillation and cardioembolic stroke	635
Abnormal left-sided blood volume, wall shear stress & energy loss in patients with repaired Tetralogy of Fallot identified by 4D flow MRI	550
Functional capacity and gender-related differences in Fabry disease	536
Injection drug use infective endocarditis: clinical features and therapeutic challanges	531
Trimetazidine as adjunctive therapy for decreasing major adverse cardiac events in coronary artery disease patients undergoing reperfusion strategy: a meta-analysis of randomized controlled trials	527
Aortic Z-scores in paediatric patients with marfan syndrome and other hereditary thoracic aortic diseases	514
Evolving trends in infective endocarditis over three decades in a developing country	461
The value of microRNA-122 in the diagnosis of coronary heart disease	438
Sex differences on new-onset heart failure in patients with known or suspected chronic coronary syndrome	438
Atrial fibrillation screening on holter monitoring after percutaneous patent foramen ovale closure: a prospective study	407
Simultaneous percutaneous closure of aortic paravalvular leak and residual shunt of ventricular septal defect	318
A blueprint for the continuation of comprehensive cardiac rehabilitation during the COVID-19 pandemic. An Australian single hospital experience	306
Quality of life in EMPEROR-Reduced: emphasizing what is important to patients while identifying strategies to support more patient-centred care	301
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	286

Involvement of FAK in aortic dissection: potential role in aortic interstitial cells	248
First-degree relatives of type-2 diabetic patients and dysglycaemic patients have impaired endothelial function due to decreased bioavailability of nitric oxide	242
Risk of dementia according to smoking cessation after newly diagnosed atrial fibrillation: a nationwide cohort study	237
Trial leadership by women is associated with racial diversity among heart failure clinical trial participants: a systematic bibliometric review 2000–2020	223
Emotional and cardiovascular health: the impact of depression on cardiac autonomic activity	197
Accuracy and acute efficacy of a novel occlusion tool to guide cryoballoon-based pulmonary vein isolation	189
Contrast-induced nephropathy after staged balloon pulmonary angioplasty: lower risk compared with left-sided cardiac procedures	186
Prevalence of target organ damage in subjects with high-normal blood pressure without known cardiovascular and kidney disease	174
Role of telemedicine network provided by pharmacies to detect acute myocardial infarction in patients with chest pain during coronavirus pandemia	171
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	170
Effect of the number of parity on right heart chamber quantification	168
Corrigendum to: The World Stroke Organization Brain & Heart Task Force: collaborations between stroke physicians and cardiologists	168
Hospital readmissions and economic burden associated with multivessel disease in the early period following acute myocardial infarction	166
Beta-blocker could show the prognostic impact in heart failure patients even on the regular hemodialysis	165
New Quality Standards Editor appointed for European Heart Journal	160
Investigating the endothelin receptor antagonist aprocitentan in resistant hypertension: design and baseline characteristics of the PRECISION study	159
Sex-related differences in mortality following an admission for acute heart failure across left ventricular ejection fraction spectrum	155
Prognostic value of heart rate reserve during dipyridamole stress echocardiography in patients with abnormal chronotropic response to exercise	153
Preponderance of right ventricular dysfunction in COVID-19 patients with inflammatory heart disease	151
Left atrial strain evaluation and prognostic value in constrictive pericarditis patients undergoing pericardiectomy	149
Speckle tracking during stress echocardiography using high frame rate imaging	148
The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension via targeting PTEN	147
Mechanoenergetic coupling in heart failure with preserved, mid-range and reduced left ventricular ejection fraction	146
Exploring the cross-talk between liver and vessels through increased morning blood pressure in hypertension	146
Cryoablation versus anti-arrhythmic therapy for initial treatment of atrial fibrillation: a systematic review and meta-analysis	146
Optimizing pre-participation screening to prevent tragedy in young athletes: moving from if to how	141
Right ventricular diverticulum: an uncommon cause of chest pain	137
From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?	125
Early-stage amyloid transthyretin cardiomyopathy: uncertainties and opportunities	124
Ambient temperature and aortic dissection: do pipes burst in freezing weather?	123
Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19	122
Longer sleep improves cardiovascular outcomes: time to make sleep a priority	122
Obituary Joep Perk	117
Transcatheter closure of a rare giant aneurysm in coronary right ventricle fistula associated with ventricular septal dissection	117
‘Our real work’: medicine and poetry with Dr Adam Possner	115
Complete primary aortic ascending thrombosis resolution after dabigatran therapy	115
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	111
Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease	111
A case of bilateral atrial myxoma straddling the foramen ovale	109
Single-cell RNA sequencing of human fetal epicardium reveals novel markers and regulators of EMT	109
Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation – insights from a cohort study of 7,412 patients with extended follow-up	107
Anticoagulant profile of supplementary-dose enoxaparin in patients undergoing prolonged percutaneous coronary intervention	107
Additive prognostic value of exercise echocardiography in symptomatic patients with normal or abnormal left ventricular diastolic function	106
Prevalence and impact of frailty in patients with atrial fibrillation: a systematic review and meta-analysis	105
Physiological circadian rhythm of cardiac myosin-binding protein C (cMyC) and cardiac troponin	104
Long-term cardiopulmonary effects after Covid-19 infection	102
Comparison of coronary flow reserve feasibility and values in different stress echocardiography protocols: dobutamine, dipyridamole, exercise and rapid pacing	102
Association between lowering heart rate during IMPELLA support and favorable short-term outcome in patients with cardiogenic shock	101
Leuko-platelet index as an independent predictor of in-hospital events in patients with non-ST elevation acute coronary syndrome	101
First results of a regenerative transcatheter heart valve implant from autologous tissue in a long-term animal model	101

Sex differences in cardio-oncology: utilizing a genetic variant as a therapeutic target doxorubicin-induced cardiomyopathy	100
Indications for prescription and deprescription in multimorbid independently living elderly outpatients	100
Short- and intermediate-term mortality in women and men after surgical versus interventional revascularization and aortic valve replacement	98
Incomplete functional reverse remodelling of the left ventricle one year after bariatric surgery. Insights from the prospective FatWest study	95
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks	94
Concomitant real-time measurement and correlation of contact force to baseline local impedance and local impedance drops in RF ablation of left and right atrial procedures	94
Usefulness of CHA2DS2-VASc scoring system for predicting risk of embolism in patients with cardiac tumours: a single-centre study	92
Gene and protein expression profiles of selected molecular targets mediating electrophysiological function in pgc-1-alpha deficient murine ventricles	92
Cardiac MRI risk factors predict atrial arrhythmia development in repaired tetralogy of Fallot patients	92
Effect of prophylactic and therapeutic low molecular weight heparins on mortality in 15,704 COVID-19 patients. A systematic review and a meta-analysis	92
Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality – insights from the German Ablation Registry	91
Hemodynamic effects of balloon pulmonary angioplasty for the treatment of total and subtotal pulmonary artery occlusions in inoperable chronic thromboembolic pulmonary hypertension	90
The effectiveness of strict low-density lipoprotein cholesterol management in secondary prevention of Japanese patients	90
The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease	90
Resveratrol regulates cytokine secretion by cardiac microvascular endothelium under hypoxia/reoxygenation condition	89
Percutaneous bioprosthetic aortic valve durability: results a single center after ten years of follow-up ago	89
Is coronary flow velocity reserve just a marker of a higher atherosclerotic burden?	88
Multiorgan and vena cava perforation by an inferior vena cava filter: surgical approach and bovine pericardial patch reconstruction	88
Percutaneous closure of latent iatrogenic left ventricular pseudoaneurysm: role of patient-specific imaging planning	88
Metabolic/bariatric surgery protects against cardiovascular disease	87
Alcohol and atrial fibrillation: not all drinks are created equal	87
A case of crowded heart: closing the door after the visitors	86
Survival or survivors?	85
Quinidine vs. ICD in patients with short-coupled idiopathic ventricular fibrillation: a call for a multicenter randomized trial	84
Left atrial pressure-assisted acute heart failure management in the cardiac intensive care unit: a proof-of-concept	83
The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile	83
Mechanistic modelling of Virchows triad to assess thrombogenicity and stroke risk in atrial fibrillation patients	83
Timing of cardiovascular magnetic resonance imaging and diagnostic yield in patients with acute myocardial infarction with nonobstructive coronary arteries	82
Socioeconomic status and trends in utilization of catheter ablation in patients hospitalized with atrial fibrillation in united states	82
Ventricular fibrillation: combined myocardial substrate and Purkinje ablation	82
Impact of pacing-related differences on clinical and echocardiographic outcomes after TAVR with SAPIEN-3 valve	81
Utilising clinical data to personlaise boundary conditions significantly improves the accuracy of angiography based virtual FFR	81
Predictors of survival in patients submitted to typical atrial flutter ablation	81
Endocardial pacing compared to epicardial left ventricle pacing and right ventricle pacing: a single center long term experience in a pediatric population	80
Routine versus clinically indicated use of chest X-rays in patients presenting with ST-elevation myocardial infarction	80
New York Heart Association class change on heart failure patients with implantable devices: does it matters?	79
How a new drug is born	79
Traditional risk factor control in the Russian cohort of the hospital arm of EUROASPIRE V survey as compared to the whole study population	79
European Heart Journal Team Heart Failure	78
Frequency and prognostic impact of periprocedural myocardial infarction determined by various MI definitions in patients with chronic coronary syndromes undergoing percutaneous coronary intervention	78
Cumulative prognostic effect of diabetes and myocardial injury in patients attended in the emergency room	78
Clinical features and outcomes in carriers of pathogenic desmoplakin variants	77
Backup natural pacemaker found in the heart	77
Desmoplakin cardiomyopathy: a step towards understanding the genetic basis of phenotypic and outcome heterogeneity	76
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial	75
Familial hypercholesterolaemia: how to further improve outcomes	75
Influence of the speed of deflation of the stent delivery system in the myocardial blush and ST-segment resolution in primary angioplasty: a randomized study	75
Mechanisms of heart failure with preserved ejection fraction, risk stratification of heart failure with reduced ejection fraction, and new light on resistance to diuretics in acute decompensated heart	74
Myocardial performance is impaired in cardiac amyloidosis: role of myocardial work-derived parameter in differential diagnosis with phenocopies and prognostic implications	74
Pharmacological blockade of histone methyltransferase SETD7 restores angiogenic response in experimental diabetes	74
Severe tricuspid regurgitation worsens prognosis outcome after edge-to-edge mitral valve repair	73
Leadless pacemaker implant in the elderly: a safe and feasible solution	73
Sex differences in the effect of family stress on risk of myocardial infarction and stroke in population 25–64 years: WHO program MONICA-psychosocial	72
Effect of interventional edge-to-edge repair in tricuspid regurgitation on ring dimensions	72
A short and long-term outcomes of heart failure with midrange and preserved ejection fraction; developing countries perspective	72
Validity and utility of the questionnaire-based FRAIL scale in elderly patients with heart failure: findings from the FRAGILE-HF	70
Adherence to guidelines of diagnostic and therapeutic practices for suspected infections of cardiac implantable electronic devices	70
Role of prenatal cardiovascular magnetic resonance imaging in determining pregnancy risk in repaired Tetralogy of Fallot patients	70
Use of sirolimus-coated balloon in de novo small vessel coronary lesions; Long-term follow-up from a single centre registry	70
Impact of diabetes mellitus on long-term survival after transcatheter mitral valve edge-to-edge repair	69
The influence of metabolic activity of platelets on sensitivity to Acetylsalicylic acid in patients with coronary heart disease	69
Mitral and tricuspid annular abnormalities in hypereosinophilic syndrome – a three-dimensional speckle-tracking echocardiographic study	68
Obesity and decreased vibration perception associated with premature cardiovascular mortality in a single center prospective study of people with diabetes	68
Prognostic significance of percutaneous coronary intervention associated blood loss in acute coronary syndrome	68
Human hyperpolarized [1-13C] pyruvate CMR and adenosine stress test	66
QRS narrowing predicts left ventricular reverse remodelling after resynchronization therapy in patients with end-stage heart failure	66
Dyssynchronous cardiomyopathy in patients with WPW syndrome and its reversibility after RFA of accessory pathway	66
Gender bias in ACS management	65
Features of disorders of uric acid metabolism in male patients with hypertension and atrial fibrillation	65
Different myocardial microRNA expression patterns are observed in pressure overload- and volume overload-induced chronic heart failure	65
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	64
Impact of transcatheter aortic valve implantation on coronary flow reserve by transthoracic Doppler echocardiography 1-year after the intervention in severe aortic stenosis patients	64
Cognitive dysfunction and adverse events during oral anticoagulant: a prospective cohort study	64
Reasons for antihypertensive medication nonadherence influence physician preferences for hypertension management	64
Follow-up on new marker confirming the optimal status in the treatment of heart failure with reduced ejection fraction	64
Twenty-year experience and outcomes in a national paediatric pulmonary hypertension service	63
Predictors of patient and system delay for primary percutaneous coronary intervention	63
Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study	62
Can machine learning augment clinician adjudication of events in cardiovascular trials? A case study of major adverse cardiovascular events (MACE) across CVRM trials	62
When the solution becomes the problem: left atrial appendage occlusion device-related thrombus after 5 years	62

Risk of sports-related sudden cardiac death in women	62
Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography a	61
Role of myocardial performance index as predictor of in-hospital cardiac events in patients with acute myocardial infarction	61
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis	61
Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury – potential role of angiotensin and purinergic signaling	60
Cardiovascular risk profile in Portugal: evidence from a large population-based cohort	60
Detecting cardiomyopathies in pregnancy and the postpartum period using ECG	60
Post-angioplasty myocardial blush grade for long term prognostication in acute coronary syndrome: a systematic review and meta-analysis	59
Long-term mortality after myocardial infarction and stroke in a simple congenital heart disease population	59
Progression of liver fibrosis in pulmonary arterial hypertension	59
An heart team stroke prevention decision-making process comparing percutaneous endocardial and thoracoscopic epicardial left atrial appendage occlusion	59
Predictors of clinical decompensation in patients presenting with COVID-19 in an urban hospital health system	59
Impact of left atrial strain assessed with feature-tracking computed tomography on long-term mortality after transcatheter aortic valve implantation	58
Subdepression effect on the therapeutic and prophylactic activity of patients with existing coronary artery disease	58
The prognostic value of monocyte/ high-density lipoprotein ratio in chronic heart failure	58
The efficacy of vericiguat on improving quality of life among patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis	58
Induction of RAGE-NFkB signalling axis enhances SHP-2 tyrosine phosphatase expression resulting in deviant activation of diabetic monocytes	58
Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure	58
Morphological features of mitral annular calcification leading to systolic anterior motion of the mitral valve	58
Incidence and predictors of left atrial appendage thrombus on transoesophageal echocardiography before elective cardioversion	57
Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up	57
Dynamic optimization of CRT pacing using a novel algorithm improves survival in a real-world cohort of patients	57
A most remarkable person: Dr Bernard Lown	57
Automated non-invasive pressure-volume loop analysis of cardiac aging in a large cohort of healthy community dwellers	56
Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction	56
Characteristics of warfarin underprescription in older adults with atrial fibrillation	56
Myocardial Work and long-term prognosis in patients after ST-segment elevation acute myocardial infarction	56
Correlation of Seattle Angina Questionnaire score and post-procedural outcomes in patients undergoing multi-vessel coronary intervention	55
Heartfelt welcome to ESC 2021	55
Prognostic significance of non-sustained ventricular tachycardia on stored electrograms of heart failure patients with cardiovascular implantable electronic devices	55
The effect of prolonged Intraaortic ballon pump (IABP) support on right ventricular function in end-stage heart failure	55
Fetal and maternal outcomes in patients with tetralogy of Fallot	55
Lifelong dietary omega-3 fatty acid reverses cardiac and vascular dysfunction via MMP-2 modulation in aged mice	55
A fourteen-year experience on treatment of atrial fibrillation with radiofrequency ablation in Thailand: a real-world report from South East Asia	54
Fluid responsiveness in patients under mechanical ventilation and low tidal volume ventilation through the pulse pressure variation after tidal volume challenge in the post-operative cardiac surgery	54
Direct comparison of adenosine- versus exercise echo-derived distal left anterior descending artery velocity reserve	54
The combination of dulaglutide and dapagliflozin improves arterial stiffness, endothelial glycocalyx and albuminuria vs DPP-4 inhibitors independently of glycemic control	54
Comparison of peripheral artery plaque characteristics between ACS patients with plaque rupture and plaque erosion in culprit coronary artery: an OCT and ultrasound study	54
Clinical outcomes in COVID-19 patients with in-hospital cardiac arrest – an insight from multi-centre data	53
A machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis	53
Serial assessment of right ventricular function and deformation in patients with hypoplastic left heart syndrome: a cardiovascular magnetic resonance study	53
The new frontiers of imaging from echocardiography to positron emission tomography, and also what happened in the last year in digital health and imaging	53
Colchicine and quality of life in patients with acute coronary syndromes: results from the COPS randomized trial	53
Cost and prescription trends of P2Y12 inhibitors in Australia over the last decade	53
Impact of induction therapy on outcomes after heart transplantation	51
Kidney subclinical lesions in hypertension phenotypes defined by Home Blood Pressure Monitoring among young adults enrolled in a Family Health Strategy unit	51
Predictability of cardiotoxicity at a Belgian cardio-oncology clinic without mandatory physician referral	51
Impact of COVID-19 pandemics upon pulmonary hypertension patients: insights from BNP-PL national database	51
Early screening for metabolic syndrome opens a window of opportunity - learnings from a long-term, population-based study	51
Clinical characteristics and natural history of pre-adolescent non-syndromic hypertrophic cardiomyopathy	50
Hypertension as a prognostic factor in the prediction of mortality in patients with COVID-19: a systematic review and meta-analysis	50
Predictors of mortality in patients with right-side and cardiac device-related infective endocarditis, the esc-eorp euro-endo registry	50
Long-term durability of transcatheter aortic valve replacement: outcomes from a contemporary cohort from a tertiary reference center at 5-years and beyond	50
Fragmented qrs as a predictor of cardiac events in patients with cardiac sarcoidosis	50
Antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome	50
Pulmonary arterial hypertension associated with congenital heart disease in children and adults: knowing the present to imagine the future	50
Dispatch of lay-responders is associated with bystander cardiopulmonary resuscitation, bystander defibrillation and 30-day survival following an out-of-hospital cardiac arrest	49
Association of neighbourhood-level poverty with outcomes and clinical care following atrial fibrillation diagnosis in a universal healthcare system	49
Echocardiogram in critically ill patients with COVID-19	49
Social-occupational impact and level of satisfaction in patients included in a remote monitoring pacemaker programme	49
Clinical characteristics and outcomes of myocardial infarction with nonobstructive coronary arteries	49
The gender differences in the implementation and maintenance of a structured-enhanced education and follow-up program in primary prevention for coronary artery disease	49
Increased VO2 peak after a structured exercise-training program is associated with reduced levels of cardiac myosin binding protein C in patients with symptomatic chronic heart failure	48
A novel research platform for sudden cardiac death based on continuous, real-life, unlimited follow-up of a cohort of high-risk patients	48
Clinical characteristics and in-hospital outcomes of patients coinfected with Chagas disease and SARS-CoV-2	47
Effects of cardiac rehabilitation on the two-year prognosis of patients with heart failure: a multicentre prospective cohort study	47
Clinical factors predicting asymptomatic atrial fibrillation in Middle Eastern patients	47
Impact of parity on cardiac structure and function in apparently healthy pregnant women in Nigeria	47
Management and clinical outcome of patients with atrial fibrillation stratified by the 4S-AF scheme for structured characterization of atrial fibrillation: data from CODE-AF registry	47
Incidence of cardiovascular events in patients with atrial fibrillation anticoagulated with rivaroxaban after 2.5 years of follow-up: not all is stroke or bleeding	46
The experience of cardiovascular professional training across europe: preliminary results from the ESC young cardiovascular professionals survey	46
Relationship between endothelium-dependent vasodilation, carotid intima-media thickness and atherosclerotic plaques: is it preserved in the elderly?	46
Transcatheter valvular interventions 2022: insights from the National Societies of Cardiology Journals of the European Society of Cardiology	46
Machine-learning fusion approach for the prediction of atrial fibrillation onset using photoplethysmographic-based smart device	46
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study	45
The relationship between epigenetic age and myocardial infarction/acute coronary syndrome and in a population based nested case-control study	45
Characteristics and prognosis of patients with elevated triglycerides in acute myocardial infarction: observational data from a large database over a 17 years period	45
Comparison between a novel sirolimus-eluting bioresorbable scaffold with everolimus-eluting metallic stent in patients with coronary artery disease: three-year follow-up from the neovas rct study	45
Low rate of worsening renal function after 2 years of treatment with edoxaban in patients from the ETNA-AF-Europe study	44
Prevalence and diagnostic yield of investigating t wave inversion in a large unselected pre-participation cohort of young Asian males	44
Gender differences in health-related quality of life among coronary patients and the relation with comorbidity burden. Results from the ESC EORP EUROASPIRE V survey	44
A machine-learning-based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease	44
Resistant hypertension improved after 3 months by measuring drug levels to identify non-adherence	44
The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?	44
The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure	44
Prognostic value of self-reported subjective exercise capacity in patients with acute dyspnea	43
Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked?	43
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	43
Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry	43
12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial	43
Weekly Journal Scan: a ‘thousand-mile’ journey in obesity-related heart failure treatment begins with a few STEPs	43
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry	43
A genetic risk score predicts recurrent events after myocardial infarction in young patients with a low level of traditional risk factors	43
Early stakeholder engagement lessons from managing hypertension among people living with human-immunodeficiency virus: an integrated model (MAP-IT)	43
Unveiling sex differences in valvular disease care and outcomes	43